 Design and Method: Program will be delivered to 135 breast cancer survivors who have completed conventional care surgery, radiation, IV chemotherapy for at least six weeks. Differences in option 1 and 2 outcomes will be compared to each other and to controls; combined outcomes of option 1 and 2 will be compared to controls; and waitlist control outcomes will be compared to their extended baseline. Hypothesis: Options 1 and 2 will both produce significantly better outcomes than waitlist control group. 